An algorithm for cell-distance analysis of multiplex fluorescence immunohistochemistry (mfIHC) staining and a framework for automated Ki-67 LI quantification were created and validated in a cohort of 12,475 prostate cancer samples in order to enable automated Ki-67 LI assessment in common clinical practice [87]. This evidence concerns the gene MKI67 and prostate carcinoma.